UNSPSC 51352007: Norelgestromin

This classification denotes a therapeutic progestin with the molecular formula C21H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R0TAY3X631, chemically known as 18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (8-alpha,9-beta,10-alpha,13-alpha,14-beta)- but generally known as norelgestromin, which bears US NIH Compound Identifier 62930. European Medicines Agency schedules Norelgestromin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20476.

UNSPSC 51352007 Norelgestromin, a Commodity code, covers the procurement of this synthetic progestin used in hormonal contraceptive products. State and local governments purchase norelgestromin primarily through health departments, public health clinics, and family planning programs that distribute contraceptive supplies to uninsured or low-income populations. The product appears in procurement as a finished pharmaceutical form — typically transdermal patches or combination oral contraceptive tablets — rather than as a raw chemical input. Issuing bodies soliciting under this code include state health departments and county public health agencies operating reproductive health programs.

The source contains no recent state and local contract opportunities tagged to this code, making it impossible to characterize current geographic activity, representative solicitations, or response dates. Without posted RFP, RFQ, IFB, or ITB records, the code does not signal active procurement momentum at the state and local level at this time.